Selective treatment pressure in colon cancer drives the molecular profile of resistant circulating tumor cell clones

The characterization of circulating tumor cells (CTCs) holds promises for precision medicine because these cells are an important clinical indicator of treatment efficacy. We established the first and still only nine permanent colon CTC lines from peripheral blood samples of a patient with metastati...

Descripción completa

Detalles Bibliográficos
Autores principales: Cayrefourcq, Laure, Thomas, Frédéric, Mazard, Thibault, Assenat, Eric, Assou, Said, Alix-Panabières, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869222/
https://www.ncbi.nlm.nih.gov/pubmed/33557844
http://dx.doi.org/10.1186/s12943-021-01326-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869222/
https://www.ncbi.nlm.nih.gov/pubmed/33557844
http://dx.doi.org/10.1186/s12943-021-01326-6

Ejemplares similares